✦ LIBER ✦

PUK27 ERYTHROPOIESIS-STIMULATING AGENT DOSING AND HEMOGLOBIN TRENDS OVER TIME IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS

✍ Scribed by MH Lafeuille; RA Bailey; F Laliberté; M Senbetta; F Vekeman; RS McKenzie; K Dea; P Lefebvre

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PUK28 ASSESSMENT OF RECENT ERYTHROPOIESI

✍ MH Lafeuille; RA Bailey; F Laliberté; M Senbetta; F Vekeman; RS McKenzie; A Blac 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PUK9 SEVEN YEAR TRENDS OF PHARMACY BENEF

✍ F Vekeman; RA Bailey; F Laliberté; M Senbetta; RS McKenzie; P Lefebvre 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

159 Assessment of Recent Erythropoiesis-

✍ Marie-Hélène Lafeuille; Natalia Mishagina; Robert A. Bailey; Mekré Senbetta; Pat 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 201 KB

PUK8 ERYTHROPOIESIS-STIMULATING AGENTS U

✍ MH Lafeuille; RA Bailey; F Laliberté; M Senbetta; A Blacksmith; P Lefebvre 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

161 Patient Characteristics Associated w

✍ Marie-Hélène Lafeuille; Robert A. Bailey; Mekré Senbetta; Patrick Lefebvre 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 234 KB

37: Dosing Trends Over Time of Epoetin A

✍ Robert A. Bailey; François Laliberté; Francis Vekeman; Mekré Senbetta; R. Scott 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 94 KB